News
Janssen reveals new Spravato data
The Janssen Pharmaceutical Companies of Johnson & Johnson has announced new findings from its pivotal ESCAPE-TRD trial.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
The Janssen Pharmaceutical Companies of Johnson & Johnson has announced new findings from its pivotal ESCAPE-TRD trial.